Overview

  • Product nameAnti-Bcl 7A antibody
    See all Bcl 7A primary antibodies
  • Description
    Rabbit polyclonal to Bcl 7A
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide conjugated to KLH, corresponding to a region within N terminal amino acids 1-30 of Human Bcl 7A (NP_001019979.1, NP_066273.1).

  • Positive control
    • NCI-H292 cell line lysates

Properties

Applications

Our Abpromise guarantee covers the use of ab107209 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 23 kDa.

Target

  • Involvement in diseaseNote=Chromosomal aberrations involving BCL7A may be a cause of B-cell non-Hodgkin lymphoma. Three-way translocation t(8;14;12)(q24.1;q32.3;q24.1) with MYC and with immunoglobulin gene regions.
  • Sequence similaritiesBelongs to the BCL7 family.
  • Post-translational
    modifications
    Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Information by UniProt
  • Database links
  • Alternative names
    • B cell CLL/lymphoma 7 antibody
    • B cell CLL/lymphoma 7 protein family member A antibody
    • B cell CLL/lymphoma 7A antibody
    • B-cell CLL/lymphoma 7 protein family member A antibody
    • BCL 7 antibody
    • BCL7 antibody
    • bcl7a antibody
    • BCL7A_HUMAN antibody
    see all

Anti-Bcl 7A antibody images

  • Anti-Bcl 7A antibody (ab107209) at 1/100 dilution + NCI-H292 cell line lysates at 35 µg

    Predicted band size : 23 kDa

References for Anti-Bcl 7A antibody (ab107209)

ab107209 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab107209.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"